BACTERIAL AND VIRAL SPECIMEN COLLECTION MARKET ANALYSIS

For the isolation, identification, and characterization of bacterial and viral agents, proper collection and transport of clinical specimens are critical. It is essential to comply with the required biosafety guidelines when dealing with potentially infectious clinical specimens to maintain a safe working environment for health care workers, patients, and laboratorians. Infection may spread from staff to patient or from patient to staff at the time of carrying out the collection procedure. Whenever possible, all culture specimens must be collected prior to the administration of any antimicrobial agents.

The global bacterial & viral specimen collection market is estimated to be valued at US$ 17,667.8 Million in 2021 and is expected to exhibit a CAGR of 13.6% during the forecast period (2021-2028).

Figure 1. Global Bacterial & Viral Specimen Collection Market Share (%), by Product Type, 2021

To learn more about this report, request a free sample copy

Increasing prevalence of bacterial and viral diseases is expected to drive the market growth during the forecast period.

The increasing number of bacterial and viral diseases such as the COVID-19, syphilis, and others is expected to drive the global bacterial & viral specimen collection market growth over the forecast period. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization (WHO), over 278.64 million cases and 5.4 million deaths due to coronavirus disease were reported till December 24, 2021, across the globe.

Figure 2. Global Bacterial & Viral Specimen Collection Market Share (%), by Application, 2021

To learn more about this report, request a free sample copy

Increasing launches of bacterial & viral specimen collection kits, transport media, and others are expected to drive the market growth during the forecast period.

Increasing launches of bacterial & viral specimen collection kits, swabs, transport media, and others are expected to fuel the global bacterial & viral specimen collection market growth over the forecast period. For instance, in November 2021, VIRCELL S.L., a microbial biotechnology company, announced the launch of a new transport medium for the collection and preservation of chlamydia, viruses, and mycoplasma, incorporating a flocked swab intended for use in pediatric patients. This new transport medium is suitable for COVID-19 testing using pharyngeal and nasopharyngeal samples.

Global Bacterial & Viral Specimen Collection Market – Impact of Coronavirus (COVID-19) Pandemic

Lockdown or shutdown due to the COVID-19 was imposed in various countries, which had a negative impact on the economy of the private healthcare sector all around the world. This lockdown resulted in the closure of industrial establishments, except the manufacturing of essential commodities, and disruption in the supply chain of products. Supply chain and manufacturing activities in countries such as the U.S., the U.K., India, China, United Arab Emirates, and others have been disrupted due to the lockdown. Additionally, countries such as Thailand, Indonesia, Singapore, and others are facing problems with the transportation of raw materials.

However, the demand for bacterial and viral specimen collection products is expected to increase during the COVID-19 pandemic, owing to the rising number of COVID-19 cases. Moreover, strong focus of market players on launching and receiving regulatory approvals for producing safe and effective COVID-19 specimen collection kits and others is expected to fuel the global bacterial & viral specimen collection market growth. For instance, in December 2020, Ellume, an Australia-based medical technology company, received authorization from the U.S. Food and Drug Administration (FDA) for the emergency use of its at-home nasal swab diagnostic test for the COVID-19. This test is the first over-the-counter (OTC) diagnostic test that can be performed at home without the aid of any health professional.

Global Bacterial & Viral Specimen Collection Market: Restraint

The major factors that hinder the global bacterial & viral specimen collection market growth include the limitations of bio specimen collection such as false positive/negative results and others. For instance, on April 17, 2020, the Washington State Department of Health was informed by UW Medicine that the procured batch of COVID-19 specimen collection kits may have quality control issues due to which the Washington State Department of Health recalled around 12,000 kits sent to tribal nations, local health jurisdictions, and state agency partners across the U.S.

Key Players

Major players operating in the global bacterial & viral specimen collection market include Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., DiaSorin S.P.A., Titan Biotech Ltd., Pretium Packaging L.L.C., and Spectrum Solutions L.L.C.